Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spiriva in COPD patients post-hospitalization
NCT01662986Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Aug 2012; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01662986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01662986.